PMA supplement
P970018 S025: BD PREPSTAIN SYSTEM
FDA PMA supplement · 135 Review Track For 30-Day Notice · Bd Diagnostic Systems
Key facts
| Original PMA | P970018 |
|---|---|
| Supplement number | S025 |
| Supplement type | 135 Review Track For 30-Day Notice |
| Reason for the supplement | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Trade name | BD PREPSTAIN SYSTEM |
| Generic name | Processor, cervical cytology slide, automated |
| Applicant | Bd Diagnostic Systems |
| Product code | MKQ |
| Received date | May 18, 2012 |
| Decision date | Nov 8, 2012 |
At a glance
- No Expedited review granted
- No Approval order on file
- No Summary of safety and effectiveness on file
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMA supplements
A PMA supplement asks FDA to approve a change to a device that already holds a premarket approval: a new indication, a design or labeling change, a manufacturing site or process change.
Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date: